Healthcare

Cochlear Limited (ASX:COH)

Industry Group : Health Care Equipment & Services | Industry Group Name : Health Care Equipment & Supplies

Market Price : AUD 225.73-11.31 (4.771%)

(as on 2021-09-26 10:27:24)

Market Cap : AUD 14.847 B

Dividend Yield (Annualized) : 1.130%

Previous Close Open Close* Day Range 52 WEEK HIGH LOW
237.04 235 225.73 224.15L 235.42 H 176.68L 257.76 H
Last Trade 225.73
Change% -4.7713
52 W H/L 257.76/176.68
EBITDA 457.2 M
NPAT After Abnormal Items 326.5 M
Equity 1.702 B
ROE% 13.82%
Total Liabilities 736.5 M
Total Revenue 1.584 B
Cash and Cash Equivalents 609.6 M

Stock Information

Share price 225.73
Market Cap 14.847 B
Price/Gross Cash Flow 53.46
Dividend Yield Excluding Special 1.01%
Ending Shares 65.744 M
52-Week Range 176.68-257.76
P/E ratio 45.455
Sector P/E --
EPS 496.70
EV/EBITDA 39.70
Net Profit Margin (%) 15.70%
Gross Cash Flows Per Share 4.71
Net Gearing -20.29%
Gross DPS (AUD) 2.55
Gross Dividend Yield (Annualized) 1.01%
Earnings Yield 2.200
Net Tangible Asset (NTA) 19.76
Sales Per Share 22.78
Book Value Per Share 25.88

Announcements

Heading Date/Time
Cochlear advises of US patent infringement complaint  24/09/2021 9:57AM
Notification regarding unquoted securities - COH  23/09/2021 11:26AM
COH Notice of Annual General Meeting and Proxy/Voting Form  16/09/2021 2:41PM
Notification regarding unquoted securities - COH  14/09/2021 3:25PM
Appendix 3Y - Diggory Howitt  09/09/2021 2:24PM
Notification regarding unquoted securities - COH  07/09/2021 2:03PM
Notification regarding unquoted securities - COH  02/09/2021 3:32PM
Notification of cessation of securities - COH  27/08/2021 3:30PM
Appendix 3Y - Christine Frances McLoughlin  27/08/2021 10:18AM
Notification regarding unquoted securities - COH  26/08/2021 2:11PM
Appendix 3Y - Diggory Howitt  25/08/2021 10:04AM
Notification regarding unquoted securities - COH  24/08/2021 2:17PM
Appendix 3Z - Rick Holliday-Smith  23/08/2021 9:47AM
Application for quotation of securities - COH  20/08/2021 11:47AM
Appendix 4G  20/08/2021 8:19AM
2021 Corporate Governance Statement  20/08/2021 8:18AM
2021 Tax Contribution Report  20/08/2021 8:16AM
2021 Sustainability Report  20/08/2021 8:16AM
FY21 Result Presentation  20/08/2021 8:15AM
FY21 Result - ASX & Media Release  20/08/2021 8:14AM
Dividend/Distribution - COH  20/08/2021 8:13AM
2021 Annual Report  20/08/2021 8:13AM
Appendix 4E  20/08/2021 8:13AM
Date of AGM and closing date for director nominations  10/08/2021 10:09AM
Appendix 3Z - Abbas Hussain  23/07/2021 3:15PM
COH Notice of FY21 result analyst and media briefing  22/07/2021 9:31AM
Resignation of Director - Abbas Hussain  20/07/2021 9:48AM
Notification of cessation of securities - COH  13/07/2021 10:31AM
Becoming a substantial holder  30/06/2021 10:29AM

Similar Companies

Related Articles

Load More

About Company

Cochlear Limited (ASX: COH) is a healthcare group and a dynamic, performance-focused organization having a range of implantable hearing solutions. The group operates through segments spanning across Americas, EMEA and Asia Pacific regions and sells products in more than 100 countries. Its products and solutions relate to Cochlear implants (Nucleus 6 System etc.), Acoustic implant solutions, Bone conduction implants (Baha Attract etc.) and Cochlear Codacs System.

Corporate Information

company address 1 University Avenue, MACQUARIE UNIVERSITY, NSW, AUSTRALIA, 2109

company phone(02) 9428 6555

company websitehttp://www.cochlear.com/

Dividends

Ex-Dividend Date Franking DPS (AUD) Dividend Yield
30/06/2021 0% 2.550 1.01%
30/06/2020 100% 1.600 1.21%
30/06/2019 100% 3.300 2.28%
30/06/2018 100% 3.000 2.14%
30/06/2017 100% 2.700 2.48%
30/06/2016 100% 2.300 2.71%
30/06/2015 69% 1.900 3.07%
30/06/2014 10% 2.540 4.29%
30/06/2013 35% 2.520 4.70%
30/06/2012 47% 2.450 4.48%

Event Calendar

Event Type Event Date Event Year
Report (Annual) 2022-08-19 2022
Report (Prelim) 2022-08-19 2022
Report (Interim) 2022-02-18 2022
AGM 2021-10-19 2021
Div Pay Date 2021-10-18 2021

Financials

Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Trading Revenue 1.498 B 1.321 B 1.427 B 1.364 B 1.254 B
Other Revenue 86.5 M 78.1 M 29 M 10.2 M 4.466 M
Total Revenue 1.584 B 1.399 B 1.456 B 1.374 B 1.258 B
Interest Income 3.6 M 1.6 M 700,000 600,000 742,000
Interest Expenses -12 M -10.5 M -5.2 M -8.5 M -7.517 M
Expenses -1.176 B -1.068 B -1.058 B -994.4 M -911.49 M
EBITDA 408.1 M 330.6 M 397.8 M 379.5 M 346.814 M
Depreciation and Amortization -79.5 M -77.5 M -38.5 M -34.2 M -31.214 M
Depreciation -56.9 M -55 M -22.9 M -20.5 M -19.352 M
Amortisation -22.6 M -22.5 M -15.6 M -13.7 M -11.862 M
EBIT 328.6 M 253.1 M 359.3 M 345.3 M 315.6 M
Pre Tax Profit 320.2 M 244.2 M 354.8 M 337.4 M 308.825 M
Tax Expense -39.2 M 32.8 M -88.9 M -94.7 M -85.209 M
Net Profit After Tax 235.1 M 189.6 M 265.9 M 242.7 M 223.616 M
Minority Interest 0 0 0 0 0
Preference Dividend 0 0 0 0 0
Net Abnormal Items 91.4 M -427.9 M 10.8 M 3.1 M 0
Reported Net Profit After Abnormal Items 326.5 M -238.3 M 276.7 M 245.8 M 223.616 M
Ending Shares 65.744 M 65.687 M 57.716 M 57.548 M 57.427 M
Weighted Average Shares 65.733 M 59.635 M 57.706 M 57.605 M 57.47 M
EPS After Abnormal Items (cents) 496.7 -399.6 479.5 426.7 389.1
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Total Current Assets 1.23 B 1.478 B 635 M 584.2 M 585.96 M
Total Non Current Assets 1.208 B 1.098 B 744.2 M 572.7 M 550.399 M
Total Assets 2.438 B 2.576 B 1.379 B 1.157 B 1.136 B
Total Current Liabilities 402.5 M 817.5 M 359.5 M 287.7 M 346.615 M
Total Non Current Liabilities 334 M 356.7 M 293.8 M 258.4 M 246.097 M
Total Liabilities 736.5 M 1.174 B 653.3 M 546.1 M 592.712 M
Net Assets 1.702 B 1.402 B 725.9 M 610.8 M 543.647 M
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Net Operating Cash 271.3 M -157.8 M 296 M 258.1 M 259.772 M
Net Invested Cash 274 M -509.7 M -137.8 M -55.4 M -135.6 M
Net Financing Cash Flows -495.1 M 1.155 B -140.9 M -232.7 M -108.287 M
End Cash Position 609.6 M 565 M 78.6 M 61.5 M 89.54 M
Beginning Cash 565 M 78.6 M 61.5 M 89.5 M 75.417 M
Exchange Rate Adjustments -5.6 M -600,000 -200,000 2 M -1.762 M
Other Cash Adjustments 0 0 0 0 0
Ending Cash 609.6 M 565 M 78.6 M 61.5 M 89.54 M

© 2021 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice or ‘regulated financial advice’ under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ) at www.morningstar.com.au/s/fsg.pdf and www.morningstar.com.au/s/fapds.pdf. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Some material is copyright and published under license from ASX Operations Pty Ltd ACN 004 523 782.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK